Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioisotopes”

206 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 206 results

Early research (Phase 1)Ended earlyNCT06390241
What this trial is testing

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer

Who this might be right for
Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02754297
What this trial is testing

Personalized PRRT of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorCarcinoma, Neuroendocrine
CHU de Quebec-Universite Laval 275
Very early researchActive Not RecruitingNCT03044977
What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting
David Bushnell 20
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT00450619
What this trial is testing

153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 44
Not applicableNot Yet RecruitingNCT07538791
What this trial is testing

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

Who this might be right for
PheochromocytomasParagangliomas
Azienda USL Reggio Emilia - IRCCS 210
Testing effectiveness (Phase 2)Study completedNCT02358356
What this trial is testing

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study

Who this might be right for
Midgut Neuroendocrine TumoursPancreatic Neuroendocrine Tumours
Australasian Gastro-Intestinal Trials Group 75
Post-approval studies (Phase 4)Study completedNCT05713396
What this trial is testing

Diabetic Autonomic Neuropathy and Left Ventricular Function

Who this might be right for
Diabetes Mellitus
AHEPA University Hospital 59
Post-approval studies (Phase 4)Looking for participantsNCT07169825
What this trial is testing

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

Who this might be right for
Lu-177 PSMA
M.D. Anderson Cancer Center 25
Not applicableStudy completedNCT02411968
What this trial is testing

Follow up After Cryoablation of Small Renal Masses.

Who this might be right for
Carcinoma, Renal Cell
Radboud University Medical Center 9
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Testing effectiveness (Phase 2)Ended earlyNCT02459613
What this trial is testing

Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis

Who this might be right for
EndocarditisThrombosis
Institut National de la Santé Et de la Recherche Médicale, France 11
Not applicableStudy completedNCT06830408
What this trial is testing

Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

Who this might be right for
mCRPC
University Hospital, Basel, Switzerland 250
Testing effectiveness (Phase 2)Looking for participantsNCT06345079
What this trial is testing

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Who this might be right for
Neuroendocrine Tumors
Australasian Gastro-Intestinal Trials Group 78
Not applicableStudy completedNCT04629937
What this trial is testing

Evaluation of Whole-body CZT Camera in Gated Tomographic Radionuclide Angiography

Who this might be right for
Cardiac Function
Centre Hospitalier Régional d'Orléans 73
Not applicableEnded earlyNCT02788578
What this trial is testing

A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours

Who this might be right for
Neuroendocrine Tumours
Ipsen 40
Testing effectiveness (Phase 2)Ended earlyNCT02736448
What this trial is testing

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors

Who this might be right for
Gastro-entero-pancreatic Neuroendocrine Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 35
Testing effectiveness (Phase 2)Looking for participantsNCT04997317
What this trial is testing

Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Who this might be right for
Meningioma
University Hospital, Basel, Switzerland 18
Not applicableStudy completedNCT03683355
What this trial is testing

Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.

Who this might be right for
Infective Endocarditis
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 30
Not applicableUnknownNCT03695991
What this trial is testing

Effect of Per-cutaneous Nephrosotomy Drainage on Radioisotope Imaging of Hydronephrotic Kidneys

Who this might be right for
Hydronephrosis
Assiut University 62
Next Page